Bharat Rasayan financials

Latest results Q1 FY27 · Apr–Jun 2026
Revenue
₹338cr−10.4% on Q1 FY26
Net profit
₹37.2cr−6.1% on Q1 FY26
EBITDA margin
15.0%−4.4 pts on Q1 FY26
EPS
₹22.40−76.5% on Q1 FY26

Quarterly results

Every quarter ›
₹ croreQ1 FY27Q1 FY26Change
Revenue338377−10.4%
EBITDA50.873.2−30.6%
EBITDA margin15.0%19.4%−4.4 pts
Profit before tax48.357.9−16.6%
Net profit37.239.7−6.1%
EPS₹22.40₹95.45−76.5%

Over time

Q1 FY27 · Apr–Jun 2026latest
Revenue₹338 crNet profit₹37.2 crNet margin11.0%

Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
1,576————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
27227228612548.6
1.21.285.280.527.9
1,305————
1,2031,2421,1731,0451,234
—+5.9%+12.3%−15.4%—
177199175117197
14.7%16.0%14.9%11.2%16.0%
15017314891.5171
14014614195.5125
11.6%11.7%12.0%9.1%10.1%
₹84.14₹87.67₹84.78₹57.46₹74.97
—+3.4%+47.5%−23.4%—
—13217241.1213
—−73.5−35.7−27.1−23.5
58.558.513614.0190
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

BHARATRAS₹948.20

Bharat Rasayan Limited

· Chemicals
₹ CrorePeersINSECTICIDIPLMOLGSPCROPPUNJABCHEMASTECBHAGCHEMNACLINDMcap ₹1,576 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————1,576.0
- Cash, Equiv & ST Investments48.6124.6285.5272.3272.3
+ Total Debt27.980.585.21.21.2
Enterprise Value————1,304.9
Revenue1,234.31,044.61,173.01,241.81,202.6
Growth %, YoY—-15.4+12.3+5.9—
EBITDA197.3117.3174.9199.1176.7
Margin %15.9911.2314.9116.0314.69
EBIT171.391.5147.9172.8149.7
Net Income124.695.5140.9145.7139.9
Margin %10.109.1412.0111.7311.63
EPS, Adj (current shares)74.9757.4684.7887.6784.14
Growth %, YoY—-23.4+47.5+3.4—
Cash from Operations213.341.1172.0132.0—
Capital Expenditures-23.5-27.1-35.7-73.5—
Free Cash Flow189.814.0136.358.558.5
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Bharat Rasayan financials and key ratios

Prices at the 29 October 2026 close · figures from the company's filings with NSE

Bharat Rasayan (NSE: BHARATRAS) had a market capitalisation of ₹1,557 crore at the 29 October 2026 close (₹936.80 a share), a PE ratio of 11.1 on the last four quarters' profit and a price-to-book ratio of 1.22. In FY26 its consolidated net profit was ₹146 crore on revenue of ₹1,242 crore; in Q1 FY27 (April–June 2026) it was ₹37.2 crore, down 6.1% year on year. Its debt-to-equity ratio was 0.00 on 31 March 2026. Promoters held 74.99% of the shares on 30 September 2026.

Share price used
₹936.80 · 29 October 2026 close
Latest balance sheet
31 March 2026
Shareholding pattern
30 September 2026

Bharat Rasayan at a glance · consolidated

Market cap
₹1,557 Crat ₹936.80 · 29 Oct close
PE ratio (last 4 quarters)
11.110.7 on FY26 profit
Price to book (PB)
1.22book value ₹766.95 a share
ROE (FY26)
12.1%−1.2 pts vs FY25ROCE 14.1%
Debt to equity
0.00net cash ₹271 Cr
Promoter holding
74.99%unchanged vs 30 Jun 202630 September 2026
Net worth
₹1,275 Cr+12.8% vs 31 Mar 202531 March 2026
Free cash flow (FY26)
₹58.5 Cr−57.1% vs FY25
EPS (FY26)
₹87.67

Questions

What is the Bharat Rasayan PE ratio today?

Bharat Rasayan's PE ratio is 11.1 at the 29 October 2026 close (₹936.80 a share): a market capitalisation of ₹1,557 crore divided by consolidated net profit of ₹140 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹146 crore) it is 10.7.

What is the Bharat Rasayan debt to equity ratio?

Bharat Rasayan's debt-to-equity ratio was 0.00 on 31 March 2026: borrowings of ₹1.2 crore against total equity of ₹1,275 crore. A year earlier, on 31 March 2025, it was 0.08.

What is the Bharat Rasayan net worth?

Bharat Rasayan's net worth — shareholders' equity in its consolidated balance sheet — was ₹1,275 crore on 31 March 2026, up 12.8% from ₹1,130 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹1,557 crore at the 29 October 2026 close.

What is the Bharat Rasayan PB ratio (price to book value)?

Bharat Rasayan's price-to-book (PB) ratio is 1.22 at the 29 October 2026 close: a market capitalisation of ₹1,557 crore divided by shareholders' equity (book value) of ₹1,275 crore on 31 March 2026. That is a book value of ₹766.95 per share against a share price of ₹936.80.

What is the Bharat Rasayan ROE and ROCE?

In FY26, Bharat Rasayan's return on equity (ROE) was 12.1% and its return on capital employed (ROCE) was 14.1%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 13.3% and ROCE 13.8%.

What is the Bharat Rasayan book value per share?

Bharat Rasayan's book value per share was ₹766.95 on 31 March 2026: shareholders' equity of ₹1,275 crore divided by the 1.66 crore shares in issue. The share price at the 29 October 2026 close was ₹936.80.

What is the Bharat Rasayan market cap?

Bharat Rasayan's market capitalisation was ₹1,557 crore at the 29 October 2026 close: 1.66 crore shares at ₹936.80 each.

Is Bharat Rasayan debt free?

No. Bharat Rasayan had borrowings of ₹1.2 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.00. Its cash and current investments were ₹273 crore, so it held net cash of ₹271 crore.

What is the Bharat Rasayan dividend in 2026 and its record date?

In 2026, Bharat Rasayan has declared one dividend: ₹0.50 with record date 17 September 2026.

What is the Bharat Rasayan EPS?

Bharat Rasayan's basic earnings per share (EPS) were ₹87.67 in FY26.

What is the Bharat Rasayan promoter holding?

Promoters held 74.99% of Bharat Rasayan on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.

When are the Bharat Rasayan next results?

Bharat Rasayan will announce its Q2 FY27 results (July–September 2026) on Friday, 13 November 2026, the date of the board meeting it has notified to the exchanges.

What is the Bharat Rasayan shareholding pattern?

On 30 September 2026, Bharat Rasayan's shares were held by promoters 74.99%, foreign portfolio investors (FII/FPI) 0.58%, domestic institutions (DII) 1.70% (including mutual funds at 1.66%) and retail and other non-institutional investors 22.72%. Over the year, FII holding was up 0.11 percentage points from 0.47% and DII holding was down 1.05 percentage points from 2.75%.

How does the Bharat Rasayan PE ratio compare with its peers?

At the 29 October 2026 closing prices, on FY26 net profit, Bharat Rasayan's PE ratio is 10.7, the lowest of the four: Insecticides 10.8, India Pesticides 10.8 and Meghmani Organics 46.6, a peer average of 22.8. Each is the company's market capitalisation at that price divided by its FY26 net profit.

Bharat Rasayan vs Insecticides: how do they compare?

In FY26, Bharat Rasayan earned net profit of ₹146 crore on revenue of ₹1,242 crore, against ₹139 crore on ₹2,140 crore for Insecticides. Bharat Rasayan's operating margin was 13.9% (Insecticides 9.0%) and its return on equity 12.1% (Insecticides 12.1%). At the 29 October 2026 close, Bharat Rasayan's market capitalisation was ₹1,557 crore against ₹1,511 crore for Insecticides, and its PE ratio on FY26 profit 10.7 against 10.8.

What is the Bharat Rasayan free cash flow?

In FY26, Bharat Rasayan generated ₹132 crore of cash from operations and spent ₹73.5 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹58.5 crore. In FY25 it was ₹136 crore.

What are the Bharat Rasayan latest quarterly results?

Bharat Rasayan's latest results are for Q1 FY27 (April–June 2026), filed on 13 August 2026: consolidated net profit ₹37.2 crore, down 6.1% from ₹39.7 crore in Q1 FY26; revenue from operations ₹338 crore, down 10.4% year on year.

What is the Bharat Rasayan revenue and profit in FY26?

In FY26 (April 2025–March 2026), Bharat Rasayan's consolidated net profit was ₹146 crore, up 3.4% from ₹141 crore in FY25, on revenue from operations of ₹1,242 crore (up 5.9%). Over three years, from FY23, net profit was up 16.9%.

How does Bharat Rasayan compare with its peers?

On FY26 consolidated figures, against Insecticides, India Pesticides and Meghmani Organics: Bharat Rasayan's operating margin of 13.9% is the second highest of the four (Insecticides 9.0%, India Pesticides 14.4%, Meghmani Organics 2.6%; peer average 8.7%); its return on equity of 12.1% is the second highest of the four (Insecticides 12.1%, India Pesticides 12.6%, Meghmani Organics 1.9%; peer average 8.8%); its revenue growth over three years of 0.2% a year is the third highest of the four (Insecticides 5.9% a year, India Pesticides 6.1% a year, Meghmani Organics −5.2% a year; peer average 2.3% a year).

Where do these Bharat Rasayan figures come from?

From Bharat Rasayan's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.